TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.

Christopher G Kanakry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.